Hormodernus - Company finances
|
EUR
|
2019
From: 2019-08-05
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | - | 132,803 | 328,273 | 358,340 | 449,163 | 532,412 | 561,675 |
| Profit before tax | -7,254 | -10,727 | 2,808 | 5,243 | 5,404 | 34,425 | 13,656 |
| Net profit | -7,254 | -10,727 | 1,335 | 3,535 | 4,319 | 29,064 | 10,372 |
| Equity | -4,754 | -15,481 | -14,145 | -10,610 | -6,290 | 22,774 | 33,146 |
| Liabilities | 37,284 | 125,869 | 127,388 | 111,669 | 120,928 | 103,343 | 123,689 |
| Non-current assets | 16,336 | 80,333 | 66,804 | 49,048 | 100,296 | 82,144 | 68,151 |
| Current assets | 16,194 | 30,055 | 46,439 | 50,104 | 14,219 | 43,771 | 88,286 |
| Total assets | 32,530 | 110,388 | 113,243 | 99,152 | 114,515 | 125,915 | 156,437 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 56,276 | 61,846 | 69,338 |
| Social insurance contributions | - | - | - | - | 61,267 | 69,286 | 75,503 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | +147.2% | +9.2% | +25.3% | +18.5% | +5.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -22.3% | -9.7% | 1.2% | 3.6% | 3.8% | 23.1% | 6.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | 127.6% | 31.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | -8.1% | 0.4% | 1.0% | 1.0% | 5.5% | 1.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | -8.1% | 0.9% | 1.5% | 1.2% | 6.5% | 2.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | 4.5 | 3.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 10,416 | 14,273 | 14,983 | 16,383 | 17,747 | 18,167 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Hormodernus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-08-19 | 2024-09-10 | 4.35 |
| 2024-07-24 | 2024-08-07 | 4.35 |
| 2024-05-16 | 2024-05-19 | 2999.00 |
| 2022-02-17 | 2022-03-06 | 0.10 |
| 2022-01-27 | 2022-02-03 | 0.10 |
| 2021-12-30 | 2022-01-09 | 0.04 |
| 2021-10-18 | 2021-10-25 | 31.37 |
Hormodernus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-08 | 2025-05-08 | 0.5 |
| 2025-05-07 | 2025-05-07 | 19.5 |
| 2025-05-03 | 2025-05-06 | 19.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Hormodernus, UAB (code 305223412) is a Private Limited Liability Company engaged in medical specialists activities. In 2025, the company generated revenue of €561.7K, up 5.5% year on year and 25.1% over two years, showing steady top-line expansion. Net profit was €10.4K, compared with €29.1K in 2024 and €4.3K in 2023, indicating that profitability improved strongly in 2024 before easing in 2025. The 2025 profit margin was 1.8%, while the reported latest margin stood at 1.9%. At year-end 2025, total assets reached €156.4K, equity was €33.1K, and liabilities amounted to €123.7K. Long-term assets were €68.2K and short-term assets €88.3K. Key ratios for 2025 show ROE of 31.3%, ROA of 6.6%, debt-to-equity of 3.73, and asset turnover of 3.59x. Revenue per employee was €18.7K, with profit per employee of €346, suggesting modest earnings relative to activity volume.